Send Message
Home ProductsRecombinant Fibronectin

Rice Grain Recombinant Human Fibronectin For FN Detection

Certification
China Wuhan Healthgen Biotechnology Corp. certification
China Wuhan Healthgen Biotechnology Corp. certification
Customer Reviews
Awesome company, highly recommended for Healthgen Biotech updates.

—— David Castillo

Healthgen Biotech has always been committed to science and scientists. Hope you will do well in new field too.

—— Frank Schauer

I'm Online Chat Now

Rice Grain Recombinant Human Fibronectin For FN Detection

Rice Grain Recombinant Human Fibronectin For FN Detection
Rice Grain Recombinant Human Fibronectin For FN Detection

Large Image :  Rice Grain Recombinant Human Fibronectin For FN Detection

Product Details:
Place of Origin: Wuhan, China (Mainland)
Brand Name: Oryzogen
Certification: ISO9001:2015 certificate
Model Number: HYC021M01
Payment & Shipping Terms:
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: 200ug, 1mg, 5mg, 10mg
Delivery Time: 3-5 days
Payment Terms: T/T
Supply Ability: 50g/month
Detailed Product Description
Brand Name: Oryzogen Catalog Number: HYC021M01
Purity: Greater Than 95% As Determined By SDS-PAGE Amino Acid Sequence: Same As The Fibronectin From Extracellular Matrix
Product Type: Recombinant Protein Certificate: ISO9001:2015 Certificate
Highlight:

Rice Grain Recombinant Human Fibronectin

,

Recombinant Human Fibronectin For FN Detection

 

Rice Grain Recombinant Human Fibronectin for FN Detection in Coronary Heart Disease

 

Specification

 

Fibronectin (FN) is mainly synthesized by liver and vascular endothelial cells and widely present in animal plasma, body fluids and tissues, and it is a particularly important and well-studied component of the extracellular matrix. FN is a macromolecular glycoprotein composed of two subunits with a molecular mass of about 220KDa connected by interchain disulfide bonds, and the molecular weight of the dimer is about 450KD. FN has a variety of biological activities. Modern medical research has shown that the change of fibronectin content is closely related to various clinical diseases, such as coronary heart disease, and the detection of fibronectin content has very important clinical significance in the auxiliary diagnosis of coronary heart disease.

 

The content of serum fibronectin in patients with coronary heart disease generally increases. The high fibronectin content state promotes the wound repair of necrotic myocardium; on the other hand, it helps to promotes platelet adhesion to the damaged parts of blood vessels, accelerates the removal of fibrin and its degradation products, maintains the dynamic balance of coagulation and fibrinolysis, which exhibiting anti-thrombotic effect. Therefore, for patients with suspected coronary heart disease, the auxiliary diagnosis of coronary heart disease can be made by detecting the content of FN in the serum.

 

Currently, the FN used to prepare FN polyclonal antibody is purified from the serum, which is limited by the availability of supply and source. In addition, due to low expression levels and difficulty of purification of recombinant fibronectin in conventional bio-reaction systems, based on its State-of-the-Art platform called OryzHiExp, having high capacity to express proteins or small peptides in the rice grain, Healthgen Biotech has produced the recombinant fibronectin (OsrhFN) using the world's top purification processing. The OsrhFN has been demonstrated that has the same physical and chemical with the plasma derived FN, and has more than 95% purity.

 

Physical Appearance: White lyophilized powder

Purity: More than 95% as determined by SDS-PAGE.

Storage condition: Stored in -20℃

 

The rice endosperm platform expressed recombinant fibronectin (OsrhFN) has such key benefits

• Free of animal prions or virus from human plasma

• Cost-effective

• Excellent batch consistency

 

Rice Grain Recombinant Human Fibronectin For FN Detection 0

 

 

Supplemental Description

 

Achievement and Honor

 

Healthgen Biotech obtained a number of patented technologies with independent intellectual property rights, including applied 9 national patents and 6 authorized patents, applied 7 international patents and 3 authorized patents. The international patents cover to United States, Japan, Europe and Canada. Moreover, two patents were authorized both by the Republic of South Africa and the United States. Based on rice endosperm specific expression technical platform-OryzHiExp, Healthgen Biotech, which aims at the international forefront, takes the market as the orientation and enhances biotechnology innovation and engineering research, has won numerous awards.

 

Scientific Research Projects:

 

Major projects for New Drug Discovery, 3 projects of "Major projects of new varieties of genetically modified organisms” of the Ministry of Agriculture, National Ministry of Science and high Technology “863 plan”, National Ministry of Science and Technology Innovation fund, Pilot development of strategic emerging industries project

 

Talents Scheme:

 

“Thousand Talents program” of the National Central Organization Department, "Hundred Talents Program" of the Organization Department of Hubei Province, "3551 talents program” of the East Lake high-technology development zone , Top 10 "Venture Eagle" entrepreneurs.

 

Research Centers and Awards:

 

Wuhan National Biological Industry Base protein purification center, Hubei Molecular Biopharmaceutical Engineering Research Center, 2013 National Science and Technology Invention Award, 2012 & 2016 Hubei Provincial Science and Technology Invention Award, 2013 China Patent Excellence Award, High-tech enterprise, Agricultural science and technology enterprise, Patent advantage enterprise.

 

 

Contact Details
Wuhan Healthgen Biotechnology Corp.

Contact Person: Ms. Abby

Tel: +86-15071115810

Fax: 86-27-59403933-59416006

Send your inquiry directly to us (0 / 3000)